Table 2.
Relative abundance of glycan parameters for complex-type N-glycans.
| IgA2 | Relative Molar Amount of Glycan Parameters (%) | |||||||
|---|---|---|---|---|---|---|---|---|
| Antibody | F | B | S0 | S > 0 | G0 | G > 0 | αGal | NeuGc |
| hTM | 64 | 15 | 32 | 62 | 3 | 91 | 0 | 0 |
| hOM | 79 | 9 | 29 | 64 | 11 | 81 | 0 | 0 |
| hPM | 82 | 12 | 29 | 68 | 4 | 92 | 0 | 0 |
| CM | 70 | 12 | 27 | 63 | 10 | 81 | 0 | 0 |
| hKM | 84 | 7 | 34 | 62 | 12 | 83 | 0 | 0 |
| IgG Erbitux | 85 | 0 | 81 | 16 | 30 | 66 | 28 | 15 |
F: glycans with fucose; B: glycans with bisecting N-acetylglucosamine; S: glycans with N-acetyl neuraminic acid; G: glycans with galactose, αGal: glycans with galactose α(1-3)-galactose (Galili epitope); NeuGc: glycans with N-glycolylneuraminic acid; numbers indicate monomer units per N-glycan.